Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-capable cells a competitive advantage over normal cells in healthy tissue, scientists have discovered. Researchers at the Wellcome Sanger Institute and the University of Cambridge studied the effects of low doses of radiation in the esophagus of mice.

July 17, 2019 — The U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) announced ...

July 17, 2019 — Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to ...

Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to quickly send 3-D DICOM volumetric data to colleagues for one-click review. The updated version provides a U.S. Food and Drug Administration (FDA)-approved 3-D DICOM web viewer with new tools such as measurements, the ability to discuss cases with messaging, viewing of mesh file types such as STL and more.

NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-99) processing facility in Beloit, Wis., with equipment installation currently underway. Establishing this processing facility is part of NorthStar’s staged development and dual processing pathway approach to expanding current capacity and efficiencies in Mo-99 production.

Featuring dual detectors, the Instadose2 dosimeter addresses international requirements for independent deep [Hp(10)] and shallow [Hp(0.07)] measurements of both photon and beta radiation.